Form EFFECT Spero Therapeutics, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | September 10, 2026 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
- IntelliXR Launches Its Platform for Eye and Brain Biomarkers
- XRP Price Prediction: Cross River Embeds RLUSD Into Core Banking as Remittix Tests Its Own Crypto-to-Bank Model
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share